NCT04777851 2026-03-09
REPLACE
Translational Research in Oncology
Phase 3 Terminated
Clinical Trials
5 trialsNCT04327700 2026-03-05
Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib
Wake Forest University Health Sciences
Phase 2 Terminated
NCT05770882 2025-03-11
Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)
Great Novel Therapeutics Biotech & Medicals Corporation
Phase 1/2 Terminated
NCT04476329 2021-12-30
ReDos HCC
SC Liver Research Consortium, LLC
Phase 2 Terminated
NCT03644511 2020-08-21
SORAGO-HCC
Bayer
Terminated